Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T23:29:41.274Z Has data issue: false hasContentIssue false
  • English
  • Français

Aripiprazole and risperidone versus placebo in schizophrenia

Published online by Cambridge University Press:  16 April 2020

P. Yeung ,
R.D. McQuade ,
W.H. Carson ,
A. Saha ,
M.W. Ali  and
G. Ingenito
P. Yeung
Affiliation:
Yale University School of Medicine, New Haven, CT
R.D. McQuade
Affiliation:
Bristol-Myers Squibb
W.H. Carson
Affiliation:
Bristol-Myers Squibb
A. Saha
Affiliation:
Otsuka Maryland Research Institute, USA
M.W. Ali
Affiliation:
Otsuka Maryland Research Institute, USA
G. Ingenito
Affiliation:
Otsuka Maryland Research Institute, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 102s - 103s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.